Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Elixir Pharmaceutical Co., Ltd., also known as the Sichuan Pharmaceutical Design Institute, is a specialized pharmaceutical company based in Chengdu, China. The company operates as a subsidiary of the Kelun Pharmaceutical Group, one of China's largest infusion and generic drug manufacturers. Sichuan Elixir focuses on the research, development, and manufacturing of a wide range of pharmaceutical products, including finished dosage forms and active pharmaceutical ingredients (APIs). Additionally, the company leverages its historical roots as a design institute to provide engineering, consulting, and technical services for pharmaceutical facility construction and optimization. Its product portfolio primarily covers therapeutic areas such as anti-infectives, cardiovascular health, and metabolic treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Elixir Pharmaceutical.